Zhenlin Huang

机构：Hubei University of Chinese Medicine, State Administration of Traditional Chinese Medicine of the People's Republic of China, Shanghai University of Traditional Chinese Medicine · ORCID：0000-0002-8286-6814

发表论文 66 篇 · 总被引 1323 次 · h-index 22

代表论文

• Caffeic acid ameliorates metabolic dysfunction-associated steatotic liver disease via alleviating oxidative damage and lipid accumulation in hepatocytes through activating Nrf2 via targeting Keap1 (2024 · Free Radical Biology and Medicine · 被引 45)
• Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: A systematic review with meta-analysis (2022 · Frontiers in Bioengineering and Biotechnology · 被引 40)
• Isotoosendanin exerts inhibition on triple-negative breast cancer through abrogating TGF-β-induced epithelial–mesenchymal transition via directly targeting TGFβR1 (2023 · Acta Pharmaceutica Sinica B · 被引 33)
• Chlorogenic acid ameliorated non-alcoholic steatohepatitis via alleviating hepatic inflammation initiated by LPS/TLR4/MyD88 signaling pathway (2023 · Chemico-Biological Interactions · 被引 32)
• Integrating network pharmacology, experimental validation and molecular docking to reveal the alleviation of Yinhuang granule on idiopathic pulmonary fibrosis (2024 · Phytomedicine · 被引 25)
• HMGB1 induced endothelial to mesenchymal transition in liver fibrosis: The key regulation of early growth response factor 1 (2022 · Biochimica et Biophysica Acta (BBA) - General Subjects · 被引 24)